Highview Capital Management LLC Sarepta Therapeutics, Inc. Transaction History
Highview Capital Management LLC
- $255 Million
- Q4 2024
A detailed history of Highview Capital Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Highview Capital Management LLC holds 1,972 shares of SRPT stock, worth $221,080. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,972
Previous 1,972
-0.0%
Holding current value
$221,080
Previous $246,000
2.85%
% of portfolio
0.09%
Previous 0.1%
Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
527Shares Held
84.9MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.16 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.01 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$702 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$489 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$479 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.82B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...